Annual direct medical cost of active systemic lupus erythematosus in five European countries-Reference-Cited by-同舟云学术

Annual direct medical cost of active systemic lupus erythematosus in five European countries

Published:2012-12-21 Issue:1 Volume:73 Page:154-160
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Doria Andrea,Amoura Zahir,Cervera Ricard,Khamastha Munther A,Schneider Matthias,Richter Jutta,Guillemin Francis,Kobelt Gisela,Maurel Frédérique,Garofano Anna,Perna Alessandra,Murray Miranda,Schmitt Claude,Boucot Isabelle

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. Systemic lupus erythematosus;Ruiz-Irastorza;Lancet,2001

2. SLE diagnosis and treatment: when early is early;Doria;Autoimmun Rev,2010

3. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics;Bertsias;Ann Rheum Dis,2008

4. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs;Bertsias;Ann Rheum Dis,2010

5. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies;Mosca;Ann Rheum Dis,2010

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socioeconomics, disparities, and disability;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Scoping review of economic analyses of rare kidney diseases;Kidney International Reports;2024-09

3. Incidence and prevalence of systemic lupus erythematosus in urban China, 2013–2017: A nationwide population-based study;Science Bulletin;2024-08

4. Navigating the landscape of SLE treatment: An expert viewpoint on the rationality and limitations of early biologic intervention;Autoimmunity Reviews;2024-08

5. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort;Annals of the Rheumatic Diseases;2024-05-16